Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed  dyslipidemias and primary hypercholesterolemia
Adie Viljoen1, Anthony S Wierzbicki21Lister Hospital, Stevenage, Hertfordshire, UK; 2Guy’s and St Thomas Hospitals, London, UKAbstract: Statins form the cornerstone of pharmaceutical cardiovascular disease prevention. However, despite very effective statin intervention, the majority of...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-05-01
|
| Series: | Drug, Healthcare and Patient Safety |
| Online Access: | http://www.dovepress.com/safety-and-efficacy-of-laropiprant-and-extended-release-niacin-combina-a4491 |